The stock has potentially broken above the short-term descending trendline, signaling a bullish reversal. Current support is near ₹3,180, with resistance at ₹3,320 (recent high). A sustained move above ₹3,320 could target ₹3,450 or higher if momentum continues.
Entry: Enter a long position if the price holds above ₹3,200
Stop Loss: Place a stop loss below ₹3,170 to protect against a false breakout.
Target: Initial target at ₹3,320, with a secondary target around ₹3,400, based on recent highs and price forecasts.
Risk Management: Watch for broader market trends and pharma sector performance, as tariffs could impact sentiment.
Entry: Enter a long position if the price holds above ₹3,200
Stop Loss: Place a stop loss below ₹3,170 to protect against a false breakout.
Target: Initial target at ₹3,320, with a secondary target around ₹3,400, based on recent highs and price forecasts.
Risk Management: Watch for broader market trends and pharma sector performance, as tariffs could impact sentiment.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。